Respiratory & Immunology金沙官网9304

金沙app旧版

金沙app旧版

金沙app旧版


金沙app旧版

金沙官网9304




金沙官网9304


金沙官网9304


金沙官网9304


金沙app旧版

Phase III/Reg. refers to assets that are in Phase III or that have been submitted for regulatory approval and may include assets that are now launched in one or more major markets.


金沙app旧版

Phase I

金沙官网9304

  • AZD0284 psoriasis/respiratory
  • AZD0449 asthma
  • AZD1402 asthma
  • AZD5634 cystic fibrosis
  • AZD8154 asthma
  • MEDI5117 China rheumatoid arthritis

Phase II

金沙官网9304

  • abediterol asthma/chronic obstructive pulmonary disease
  • anifrolumab lupus nephritis
  • anifrolumab systemic lupus erythematosus (subcutaneous)
  • AZD7986 chronic obstructive pulmonary disease
  • AZD9567 rheumatoid arthritis/respiratory
  • MEDI3506 chronic obstructive pulmonary disease and atopic dermatitis
  • navafenterol (AZD8871) chronic obstructive pulmonary disease
  • tezepelumab atopic dermatitis
  • tezepelumab chronic obstructive pulmonary disease
  • velsecorat (AZD7594) asthma/chronic obstructive pulmonary disease

Phase III

金沙官网9304

  • anifrolumab TULIP systemic lupus erythematosus
  • Bevespi Aerosphere (PT003) chronic obstructive pulmonary disease
  • Breztri Aerosphere (PT010) chronic obstructive pulmonary disease
  • Fasenra CALIMA SIROCCO ZONDA BISE BORA GREGALE MIRACLE severe uncontrolled asthma
  • nirsevimab passive RSV immunisation
  • PT027 asthma
  • tezepelumab NAVIGATOR SOURCE severe uncontrolled asthma

LCM Projects

金沙官网9304

  • Breztri (PT010) asthma
  • Duaklir Genuair chronic obstructive pulmonary disease
  • Fasenra MANDARA eosinophilic granulomatosis with polyangiitis
  • Fasenra OSTRO ORCHID (Japan/China) nasal polyposis
  • Fasenra RESOLUTE chronic obstructive pulmonary disease
  • Symbicort SYGMA as-needed use in mild asthma



金沙官网9304


金沙app旧版

金沙官网9304


Accolate, Accoleit, Vanticon金沙官网9304

zafirlukast

Bevespi Aerosphere金沙官网9304

glycopyrronium/formoterol fumarate

Breztri Aerosphere金沙官网9304

budesonide/glycopyrronium/formoterol fumarate

Bricanyl Respules金沙官网9304

terbutaline

Bricanyl Turbuhaler金沙官网9304

terbutaline in a dry powder inhaler

Daliresp/Daxas金沙官网9304

roflumilast

Duaklir Genuair金沙官网9304

aclidinium/formoterol

Eklira Genuair/Tudorza/Bretaris金沙官网9304

aclidinium, a LAMA

Fasenra金沙官网9304

benralizumab

Oxis Turbuhaler金沙官网9304

Oxis Turbuhaler

Pulmicort Respules金沙官网9304

budesonide inhalation suspension

Pulmicort Turbuhaler金沙官网9304

budesonide

Rhinocort金沙官网9304

budesonide

Symbicort pMDI金沙官网9304

budesonide/formoterol

Symbicort Turbuhaler金沙官网9304

budesonide/formoterol


金沙官网9304



Veeva ID: Z4-23796

Date of next review: April 2022